These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36602859)

  • 1. Outcomes of COVID-19 in patients vaccinated and unvaccinated against SARS-CoV-2 and suffering from pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Wieteska-Miłek M; Kuśmierczyk-Droszcz B; Ryczek R; Szmit S; Florczyk M; Mańczak R; Betkier-Lipińska K; Hoffman P; Krzesiński P; Torbicki A; Kurzyna M
    Pol Arch Intern Med; 2023 May; 133(5):. PubMed ID: 36602859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Survey-based Estimate of COVID-19 Incidence and Outcomes among Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension and Impact on the Process of Care.
    Lee JD; Burger CD; Delossantos GB; Grinnan D; Ralph DD; Rayner SG; Ryan JJ; Safdar Z; Ventetuolo CE; Zamanian RT; Leary PJ
    Ann Am Thorac Soc; 2020 Dec; 17(12):1576-1582. PubMed ID: 32726561
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 Vaccination in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Safety Profile and Reasons for Opting against Vaccination.
    Wieteska-Miłek M; Szmit S; Florczyk M; Kuśmierczyk-Droszcz B; Ryczek R; Kurzyna M
    Vaccines (Basel); 2021 Nov; 9(12):. PubMed ID: 34960141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review of Clinical Trial Endpoints of Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension and How They Relate to Patient Outcomes in the United States.
    Divers C; Platt D; Wang E; Lin J; Lingohr-Smith M; Mathai SC
    J Manag Care Spec Pharm; 2017 Jan; 23(1):92-104. PubMed ID: 28025931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive screening using ventilatory gas analysis to distinguish between chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension.
    Akizuki M; Sugimura K; Aoki T; Kakihana T; Tatebe S; Yamamoto S; Sato H; Satoh K; Shimokawa H; Kohzuki M
    Respirology; 2020 Apr; 25(4):427-434. PubMed ID: 31261445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dead-space ventilation is linked to exercise capacity and survival in distal chronic thromboembolic pulmonary hypertension.
    Godinas L; Sattler C; Lau EM; Jaïs X; Taniguchi Y; Jevnikar M; Weatherald J; Sitbon O; Savale L; Montani D; Simonneau G; Humbert M; Laveneziana P; Garcia G
    J Heart Lung Transplant; 2017 Nov; 36(11):1234-1242. PubMed ID: 28666570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical observations of COVID-19 infection in patients with chronic thromboembolic pulmonary hypertension.
    Kamenskaya OV; Loginova IY; Klinkova AS; Lomivorotov VV; Chernyavsky AM
    Kardiologiia; 2021 Jul; 61(6):28-34. PubMed ID: 34311685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Instrumental Characteristics of Newly Diagnosed Patients with Various Forms of Pulmonary Hypertension according to the Russian National Registry.
    Chazova IY; Martynyuk TV; Valieva ZS; Gratsianskaya SY; Aleevskaya AM; Zorin AV; Nakonechnikov SN
    Biomed Res Int; 2020; 2020():6836973. PubMed ID: 32626754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factor Profiles Achieved with Medical Therapy in Prevalent Patients with Pulmonary Arterial and Distal Chronic Thromboembolic Pulmonary Hypertension.
    Bartenstein P; Saxer S; Appenzeller P; Lichtblau M; Schwarz EI; Ulrich S
    Respiration; 2018; 96(2):127-137. PubMed ID: 29642071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of high density lipoprotein cholesterol and outcomes in chronic thromboembolic pulmonary hypertension.
    Khirfan G; Tejwani V; Wang X; Li M; DiDonato J; Dweik RA; Smedira N; Heresi GA
    PLoS One; 2018; 13(5):e0197700. PubMed ID: 29813091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and survival of adult Swedish PAH and CTEPH patients 2000-2014.
    Rådegran G; Kjellström B; Ekmehag B; Larsen F; Rundqvist B; Blomquist SB; Gustafsson C; Hesselstrand R; Karlsson M; Kornhall B; Nisell M; Persson L; Ryftenius H; Selin M; Ullman B; Wall K; Wikström G; Willehadson M; Jansson K;
    Scand Cardiovasc J; 2016 Aug; 50(4):243-50. PubMed ID: 27146648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Benza RL; Langleben D; Hemnes AR; Vonk Noordegraaf A; Rosenkranz S; Thenappan T; Hassoun PM; Preston IR; Ghio S; Badagliacca R; Vizza CD; Lang IM; Meier C; Grünig E
    Eur Respir Rev; 2022 Dec; 31(166):. PubMed ID: 36198418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survival in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Insights from a referral center in Portugal.
    Santos M; Gomes A; Cruz C; Rocha J; Ricardo M; Gonçalves F; Carvalho L; Vicente M; Melo A; Reis A
    Rev Port Cardiol (Engl Ed); 2018 Sep; 37(9):749-757. PubMed ID: 30144959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of Riociguat and Its Role in the Treatment of Pulmonary Hypertension.
    Kenny M; Clarke MM; Pogue KT
    J Pharm Pract; 2022 Jun; 35(3):437-444. PubMed ID: 33084500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic thromboembolic pulmonary hypertension is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studies.
    Reddy SA; Newman J; Leavy OC; Ghani H; Pepke-Zaba J; Cannon JE; Sheares KK; Taboada D; Bunclark K; Lawrie A; Sudlow CL; Berry C; Wild JM; Mitchell JA; Quint J; Rossdale J; Price L; Howard LS; Wilkins M; Sattar N; Chowienczyk P; Thompson R; Wain LV; Horsley A; Ho LP; Chalmers JD; Marks M; Poinasamy K; Raman B; Harris VC; Houchen-Wolloff L; Brightling CE; Evans RA; Toshner MR;
    Eur Respir J; 2024 Aug; 64(2):. PubMed ID: 39060016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long COVID syndrome after SARS-CoV-2 survival in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Wieteska-Miłek M; Kuśmierczyk-Droszcz B; Betkier-Lipińska K; Szmit S; Florczyk M; Zieliński P; Hoffman P; Krzesińki P; Kurzyna M
    Pulm Circ; 2023 Apr; 13(2):e12244. PubMed ID: 37266140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differences in hemodynamics of thromboembolic and primary pulmonary hypertension].
    Polanowski T; Kurzyna M; Kuca P; Tomkowski W; Fijałkowska A; Kober J; Torbicki A
    Pol Arch Med Wewn; 2000 Nov; 104(5):741-5. PubMed ID: 11434085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From Health-Related Quality of Life (HRQoL) of Patients with Pulmonary Hypertension to Patient Experience with the Care Received: Should We Be More Aware of Current Patient Needs?
    Martínez Meñaca A; Blanco Vich I; López Meseguer M; López Reyes R; Bedate Díaz P; Elías Hernández T; Fernández-Cuesta Peñafiel I; Fernández G; Álvez Liste A; Escribano Subías P
    Adv Ther; 2021 Apr; 38(4):1860-1875. PubMed ID: 33675523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Micronutrient Deficiencies and Relationship with Clinical and Patient-Related Outcomes in Pulmonary Hypertension Types I and IV.
    Vinke P; Koudstaal T; Muskens F; van den Bosch A; Balvers M; Poland M; Witkamp RF; van Norren K; Boomars KA
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic thromboembolic and pulmonary arterial hypertension share right ventricular and pulmonary artery CMR features.
    Hoette S; Creuzé N; Rochitte CE; Simonneau G; Humbert M; Souza R; Chemla D
    Pulmonology; 2019; 25(4):248-251. PubMed ID: 31080042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.